Gilead Sciences (GILD) EBT Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,755.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-3,737.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-552.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,950.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-3.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,234.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
372.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
168.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,234.00 |
| Dec 31, 2025 |
-241.00 |
| Sep 30, 2025 |
3,420.00 |
| Jun 30, 2025 |
478.00 |
| Mar 31, 2025 |
9,183.00 |
| Dec 31, 2024 |
539.00 |
| Sep 30, 2024 |
-2,020.00 |
| Jun 30, 2024 |
546.00 |
| Mar 31, 2024 |
-8,756.00 |
| Dec 31, 2023 |
-425.00 |
| Sep 30, 2023 |
-166.00 |
| Jun 30, 2023 |
5.00 |
| Mar 31, 2023 |
2,277.00 |
| Dec 31, 2022 |
1,701.00 |
| Sep 30, 2022 |
-1,179.00 |
| Jun 30, 2022 |
-522.00 |
| Mar 31, 2022 |
-3,755.00 |
| Dec 31, 2021 |
-1,397.00 |
| Sep 30, 2021 |
3,378.00 |
| Jun 30, 2021 |
8,703.00 |
| Mar 31, 2021 |
-85.00 |
| Dec 31, 2020 |
-789.00 |
| Sep 30, 2020 |
3,933.00 |
| Jun 30, 2020 |
-10,020.00 |
| Mar 31, 2020 |
-840.00 |
| Dec 31, 2019 |
1,480.00 |
| Sep 30, 2019 |
-7,439.00 |
| Jun 30, 2019 |
546.00 |
| Mar 31, 2019 |
454.00 |
| Dec 31, 2018 |
-1,820.00 |
| Sep 30, 2018 |
-877.00 |
| Jun 30, 2018 |
-2,069.00 |
| Mar 31, 2018 |
-1,565.00 |
| Dec 31, 2017 |
-1,781.00 |
| Sep 30, 2017 |
-64.00 |
| Jun 30, 2017 |
105.00 |
| Mar 31, 2017 |
-216.00 |
| Dec 31, 2016 |
-1,037.00 |
| Sep 30, 2016 |
-895.00 |
| Jun 30, 2016 |
-1,028.00 |
| Mar 31, 2016 |
-1,123.00 |
| Dec 31, 2015 |
609.00 |
| Sep 30, 2015 |
1,017.00 |
| Jun 30, 2015 |
96.00 |
| Mar 31, 2015 |
1,000.00 |
| Dec 31, 2014 |
2,218.00 |
| Sep 30, 2014 |
1,700.00 |
| Jun 30, 2014 |
2,702.00 |
| Mar 31, 2014 |
2,186.00 |
| Dec 31, 2013 |
-385.00 |
| Sep 30, 2013 |
-40.00 |
| Jun 30, 2013 |
-144.00 |
| Mar 31, 2013 |
783.00 |
| Dec 31, 2012 |
229.00 |
| Sep 30, 2012 |
-676.00 |
| Jun 30, 2012 |
-566.00 |
| Mar 31, 2012 |
-1,610.00 |
| Dec 31, 2011 |
-279.00 |
| Sep 30, 2011 |
-364.00 |
| Jun 30, 2011 |
-556.00 |
| Mar 31, 2011 |
-1,020.00 |
| Dec 31, 2010 |
-1,213.00 |
| Sep 30, 2010 |
13.00 |
| Jun 30, 2010 |
567.00 |
| Mar 31, 2010 |
361.00 |
